Why the study?
Does transcatheter aortic valve replacement improve outcomes compared to surgical aortic valve replacement in patients with severe, symptomatic aortic stenosis?
Does transcatheter aortic valve replacement improve outcomes compared to surgical aortic valve replacement in patients with severe, symptomatic aortic stenosis?
TAVR is anticipated to become the treatment of choice for a broader spectrum of patients with symptomatic aortic stenosis, including those at lower surgical risk.
Answers are grounded in this paper and cite their sources.
May broaden TAVR use in symptomatic aortic stenosis; leaves open confirmation from low-risk RCTs.
SAVR and advances in transcatheter valve technology as well as issues that merit further investigation are further discussed. Moreover, outcomes and complications of TAVR in patients of different risk category (extremely high, high, intermediate and low risk) are analyzed. We strongly believe that during the following years, TAVR may evolve as the treatment of choice in a broader group of patients with symptomatic AS and beyond those with intermediate and high-risk features.
No takes yet. Share an insight, caveat, or question.
Tsigkas et al. (2018) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: